Trademark Overview
On Friday, May 31, 2024, a trademark application was filed for NEULOGIQ with the United States Patent and Trademark Office. The USPTO has given the NEULOGIQ trademark a serial number of 79411918. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, January 24, 2025. This trademark is owned by Cumulus Neuroscience Limited. The NEULOGIQ trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; electronic scientific laboratory research apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; downloadable computer games software; downloadable computer software and applications for the provision of medical and pharmaceutical information and reports; downloadable computer software and applications for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury, insult and mental illness in human beings and other animals; wireless headsets for smartphones and tab...
Medical services; medical screening and testing services; medical evaluation services for neurological diseases; medical examination being health assessment services; neurological and cognitive testing and analysis for medical purposes; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical advisory services, namely, measurement and prediction of response to medical treatments; human healthcare services, namely, neurology and psychiatric healthcare services; medical treatment services of neurological diseases, brain injuries and mental illnesses; medical diagnostic reporting services, namely, preparation of reports relating to medical matters; information, advisory and consultancy services in relation to the aforesaid services.
Medical apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; medical apparatus and instruments, namely, sensors to be worn by a human for storing, relaying, tracking, measuring and displaying human cognitive and biometric data; medical apparatus and instruments for storing, relaying, tracking, and measuring the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury or insult and mental illness in human beings and other animals, and for displaying associated neurological and psychiatric data; medical diagnostic and testing apparatus and instruments for detecting neurological diseases, brain injuries and mental illnesses; medical apparatus and instruments, namely, electroencephalogram (EEG) for the therapeutic and medical treatment of dise...
Design and development of computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; product development, namely, design and development of electronic apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; design and development of computer games software; design and development of computer software and mobile and tablet application software for the provision of medical and pharmaceutical information and reports; design and development of computer software and mobile and tablet application software for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological disease, ...
